Sabra Health Care REIT, Inc. (SBRA) Stock Analysis and Metrics

Sabra Health Care REIT

NASDAQ: SBRA

$22.35 ▲ +0.32 (+1.48%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap5.09 Bn

P/E36.93

P/S17.13

Div. Yield0.06

ROIC (Qtr)0.00

Total Debt (Qtr)42.76 Mn

Add ratio to table…

About

Sabra Health Care REIT, Inc. operates as a self administered self managed real estate investment trust that acquires finances and owns healthcare real estate properties across the United States and Canada. The company leases these properties to third party operators or holds them under management agreements, providing housing and care services for seniors patients and individuals needing behavioral health or hospital care.

Sabra generates revenue primarily from triple net lease payments on its owned properties where tenants cover taxes insurance and maintenance. Additional income comes from management fees for senior housing communities operated by third parties, interest income on loans receivable, and dividends from preferred equity investments. The company's customers are healthcare operators including skilled nursing providers senior housing operators behavioral health providers and hospital operators.

Sabra Health Care REIT, Inc. organizes its operations into five reportable segments: Skilled Nursing/Transitional Care Senior Housing Leased Senior Housing Managed Behavioral Health and Specialty Hospitals and Other.

• This segment includes skilled nursing and transitional care facilities that provide nursing therapy rehabilitation medication management and daily living assistance to patients requiring short or long term care. The properties are leased under triple net agreements to operators who handle all operating expenses.

• This segment consists of independent living assisted living memory care and continuing care retirement communities that are leased to third party operators under triple net leases. Services range from housing and housekeeping to assistance with activities of daily living.

• This segment comprises senior housing communities operated by third party property managers under management agreements. The company retains exposure to operational performance while receiving management fees and avoids direct credit risk of the managers.

• This segment includes addiction treatment centers and behavioral hospitals that offer inpatient and outpatient care for substance abuse and mental health conditions. Properties are leased to operators who provide clinical services and the company receives lease income.

• This segment covers acute care long term acute care rehabilitation hospitals and other facilities such as residential services that are not classified elsewhere. These properties are leased to healthcare providers who deliver specialized medical services.

Sabra holds a mid size position within the healthcare REIT sector competing with larger peers such as Welltower Ventas and Healthpeak. Its competitive advantages stem from a geographically diversified portfolio a long weighted average lease term and strong relationships with a broad network of operators. The company also benefits from a disciplined capital allocation approach that emphasizes balance sheet strength and liquidity.

The company's tenants and operators are primarily skilled nursing facilities senior housing communities behavioral health centers and hospitals. No single tenant accounts for ten percent or more of total revenue indicating a diversified tenant base across the United States and Canada.

Investment Thesis

▲ Bull case

Sabra Health Care REIT's strategic pivot toward private pay concentration represents a material, underappreciated shift that significantly derisks the portfolio against reimbursement volatility while unlocking higher-margin growth avenues. Management confirmed private pay now constitutes 50% of the portfolio for the first time in company history—a milestone achieved through deliberate transition from a 96% skilled nursing-heavy mix. This evolution reduces reliance on Medicaid/Medicare reimbursement cycles, which management acknowledged are reverting to historical norms post-pandemic inflation spikes. Private pay residents typically generate superior RevPAR growth, as evidenced by Canadian communities achieving 9.6% year-over-year revenue growth and 93.4% occupancy—eight consecutive quarters above 90%. The company's ability to sustain 7.9% same-store revenue growth and 14.4% cash NOI growth in managed senior housing, despite only 1.8% expense per occupied room increases, demonstrates operating leverage that will amplify as private pay scales further. This structural shift positions SBRA to capture premium pricing power in assisted living and memory care segments, where demand is driven by aging demographics rather than government payment schedules, making earnings less susceptible to policy shifts than peers still weighted toward skilled nursing.
The confluence of AI-driven operational scalability and a $1.2 billion liquidity fortress creates a hidden catalyst for accelerated investment deployment without proportional G&A expansion—directly addressing a core constraint in the SHOP sector. Management explicitly stated that corporate and facility-level AI initiatives are expected to materialize operational benefits within 90 days, including faster decision-making, deeper portfolio insights, and reduced manual processes. Crucially, they emphasized that AI will permit "accelerated investment volume without commensurate increases in G&A," breaking the historical link between portfolio growth and overhead costs. This is reinforced by their disciplined use of forward equity issuances ($128 million issued at $20.19 average price) and ATM program ($353 million remaining capacity) to fund investments on a leverage-neutral basis. With net debt to adjusted EBITDA at 5.04x (in line with target) and no floating-rate debt exposure in permanent capital, SBRA has both the dry powder and financial flexibility to deploy its $690 million actively pursued managed senior housing pipeline. The market underestimates how these AI efficiencies will convert top-line growth into bottom-line expansion, particularly as same-store SHOP NOI growth of 14.4% already exceeds the low-to-mid teens guidance range, indicating inherent operating leverage that AI will further enhance.
SBRA's disciplined investment approach in secondary markets offers a sustainable yield advantage that contrasts with cap rate compression in primary markets, providing a structural edge in deal execution and long-term value creation. Management repeatedly noted their focus on secondary markets, where they are "not seeing the same level of cap rate compression" as in primary markets, allowing them to secure investments with estimated initial cash yields of 8% year-to-date—significantly above the low-7% market average for stabilized assets. This strategy is amplified by their pipeline composition: 95%+ of opportunities are SHOP, with skilled nursing sourced exclusively off-market via existing relationships, reducing competition and enabling disciplined underwriting. The company's ability to generate 6.5% Canadian RevPAR growth and maintain occupancy above 90% for eight consecutive quarters in Canada—despite broader sector pressures—demonstrates superior asset selection in less contested geographies. Furthermore, their value-add pipeline targeting 6% initial yields with clear stabilization paths offers meaningful IRR upside, as highlighted by Darrin Smith's commentary on opportunities "in the 6s" that should provide "more meaningful IRRs with the upside opportunity." This approach avoids the bidding wars inflating costs in primary markets, positioning SBRA to achieve superior risk-adjusted returns while peers chase lower-yielding, overpriced assets in saturated markets.

Sabra Health Care REIT's strategic pivot toward private pay concentration represents a material, underappreciated shift that significantly derisks the portfolio against reimbursement volatility while unlocking higher-margin growth avenues. Management confirmed private pay now constitutes 50% of the portfolio for the first time in company history—a milestone achieved through deliberate transition from a 96% skilled nursing-heavy mix. This evolution reduces reliance on Medicaid/Medicare reimbursement cycles, which management acknowledged are reverting to historical norms post-pandemic inflation spikes. Private pay residents typically generate superior RevPAR growth, as evidenced by Canadian communities achieving 9.6% year-over-year revenue growth and 93.4% occupancy—eight consecutive quarters above 90%. The company's ability to sustain 7.9% same-store revenue growth and 14.4% cash NOI growth in managed senior housing, despite only 1.8% expense per occupied room increases, demonstrates operating leverage that will amplify as private pay scales further. This structural shift positions SBRA to capture premium pricing power in assisted living and memory care segments, where demand is driven by aging demographics rather than government payment schedules, making earnings less susceptible to policy shifts than peers still weighted toward skilled nursing.
The confluence of AI-driven operational scalability and a $1.2 billion liquidity fortress creates a hidden catalyst for accelerated investment deployment without proportional G&A expansion—directly addressing a core constraint in the SHOP sector. Management explicitly stated that corporate and facility-level AI initiatives are expected to materialize operational benefits within 90 days, including faster decision-making, deeper portfolio insights, and reduced manual processes. Crucially, they emphasized that AI will permit "accelerated investment volume without commensurate increases in G&A," breaking the historical link between portfolio growth and overhead costs. This is reinforced by their disciplined use of forward equity issuances ($128 million issued at $20.19 average price) and ATM program ($353 million remaining capacity) to fund investments on a leverage-neutral basis. With net debt to adjusted EBITDA at 5.04x (in line with target) and no floating-rate debt exposure in permanent capital, SBRA has both the dry powder and financial flexibility to deploy its $690 million actively pursued managed senior housing pipeline. The market underestimates how these AI efficiencies will convert top-line growth into bottom-line expansion, particularly as same-store SHOP NOI growth of 14.4% already exceeds the low-to-mid teens guidance range, indicating inherent operating leverage that AI will further enhance.
SBRA's disciplined investment approach in secondary markets offers a sustainable yield advantage that contrasts with cap rate compression in primary markets, providing a structural edge in deal execution and long-term value creation. Management repeatedly noted their focus on secondary markets, where they are "not seeing the same level of cap rate compression" as in primary markets, allowing them to secure investments with estimated initial cash yields of 8% year-to-date—significantly above the low-7% market average for stabilized assets. This strategy is amplified by their pipeline composition: 95%+ of opportunities are SHOP, with skilled nursing sourced exclusively off-market via existing relationships, reducing competition and enabling disciplined underwriting. The company's ability to generate 6.5% Canadian RevPAR growth and maintain occupancy above 90% for eight consecutive quarters in Canada—despite broader sector pressures—demonstrates superior asset selection in less contested geographies. Furthermore, their value-add pipeline targeting 6% initial yields with clear stabilization paths offers meaningful IRR upside, as highlighted by Darrin Smith's commentary on opportunities "in the 6s" that should provide "more meaningful IRRs with the upside opportunity." This approach avoids the bidding wars inflating costs in primary markets, positioning SBRA to achieve superior risk-adjusted returns while peers chase lower-yielding, overpriced assets in saturated markets.

▼ Bear case

Sabra Health Care REIT's reliance on value-based care and AI initiatives as growth drivers contains significant execution risk, as management admitted these are still in early stages with uncertain timelines for financial impact, creating a potential disconnect between current optimism and near-term reality. While leadership expressed enthusiasm for value-based care programs—citing operator agreements and ACO arrangements—they conceded they are "not seeing that much impact yet" on referral rates from hospitals, directly contradicting the bullish narrative that this is a near-term catalyst. Similarly, AI initiatives were framed as having "90-day milestones" for near-term benefits, but Darrin Smith tempered expectations by stating G&A savings would be incremental and ongoing, with tangible operator performance improvements "hard to tell" in timing. This vagueness suggests the market may be overestimating the speed and scale of these initiatives' contribution to earnings, especially given that normalized AFFO per share growth slowed to 5% year-over-year despite strong top-line metrics. The company's dependence on these unproven levers to drive margin expansion beyond current operating leverage gains could lead to disappointment if implementation lags, particularly as competitors also invest heavily in similar technologies, diluting any potential first-mover advantage.
The skilled nursing portfolio, while currently showing strength, faces structural headwinds from persistent labor challenges and shifting acuity that management downplayed, creating a hidden vulnerability in the portfolio's perceived stability and diversification benefits. Although management highlighted all-time highs in rent coverage, margins, and occupancy for skilled nursing, they privately acknowledged labor remains a "meaningfully tougher" backdrop in behavioral health per peer discussions—and by extension, likely affects skilled nursing too—while insisting they have "not seen that at all" in their portfolio. This evasiveness ignores industry-wide reports of wage pressure and staffing shortages that continue to pressure operating costs, especially as acuity shifts post-pandemic. Furthermore, the disposition of three Maryland skilled nursing facilities to CommuniCare at a 6.8% lease yield—well below the typical 9%-10% range—was explicitly framed as a unique situation, yet management conceded skilled nursing deal flow is "very heavily competitive" with private buyers able to "pay up a little bit more," implying their triple-net SNF yields are under pressure from more aggressive OpCo/PropCo buyers. With skilled nursing still representing a meaningful portion of the portfolio despite the shift toward SHOP, any deterioration in this segment—driven by labor inflation or reimbursement changes—could undermine the portfolio's all-time high metrics and erode the diversification benefit management relies on for earnings stability.
SBRA's aggressive investment pipeline execution assumptions are overly optimistic given historical deal closure rates in competitive environments, risking a material shortfall in invested capital that would undermine growth guidance and leverage targets, despite management's confidence in closing the $200 million awarded pipeline. While leadership expressed no doubt about closing the $200 million awarded investments ($107 million SHOP, $94 million skilled nursing), they admitted it is "hard to tell" what percentage of the $690 million actively pursued pipeline will close due to competitive pressures, with Darrin Smith noting only a "fair number" expectation. This contrasts sharply with Richard Matros' assertion that they will "exceed pretty materially" last year's investments—a claim unsupported by historical execution rates in a rising interest rate environment where cap rate pressure is evident (most market opportunities in low-7% range). The company's reliance on forward equity issuances to fund investments on a leverage-neutral basis assumes seamless conversion of pipeline to closed deals, yet their own acknowledgment of a "competitive environment" and lack of historical closing rate disclosure suggests the market is ignoring the probability of pipeline slippage. If only 50% of the $690 million pursued pipeline closes—a conservative estimate given competitive dynamics—SBRA would deploy ~$345 million less than implied, straining liquidity and forcing either reduced investment activity (hurting growth) or increased leverage (violating target metrics), directly contradicting the narrative of ample dry powder supporting guidance stability.

Sabra Health Care REIT's reliance on value-based care and AI initiatives as growth drivers contains significant execution risk, as management admitted these are still in early stages with uncertain timelines for financial impact, creating a potential disconnect between current optimism and near-term reality. While leadership expressed enthusiasm for value-based care programs—citing operator agreements and ACO arrangements—they conceded they are "not seeing that much impact yet" on referral rates from hospitals, directly contradicting the bullish narrative that this is a near-term catalyst. Similarly, AI initiatives were framed as having "90-day milestones" for near-term benefits, but Darrin Smith tempered expectations by stating G&A savings would be incremental and ongoing, with tangible operator performance improvements "hard to tell" in timing. This vagueness suggests the market may be overestimating the speed and scale of these initiatives' contribution to earnings, especially given that normalized AFFO per share growth slowed to 5% year-over-year despite strong top-line metrics. The company's dependence on these unproven levers to drive margin expansion beyond current operating leverage gains could lead to disappointment if implementation lags, particularly as competitors also invest heavily in similar technologies, diluting any potential first-mover advantage.
The skilled nursing portfolio, while currently showing strength, faces structural headwinds from persistent labor challenges and shifting acuity that management downplayed, creating a hidden vulnerability in the portfolio's perceived stability and diversification benefits. Although management highlighted all-time highs in rent coverage, margins, and occupancy for skilled nursing, they privately acknowledged labor remains a "meaningfully tougher" backdrop in behavioral health per peer discussions—and by extension, likely affects skilled nursing too—while insisting they have "not seen that at all" in their portfolio. This evasiveness ignores industry-wide reports of wage pressure and staffing shortages that continue to pressure operating costs, especially as acuity shifts post-pandemic. Furthermore, the disposition of three Maryland skilled nursing facilities to CommuniCare at a 6.8% lease yield—well below the typical 9%-10% range—was explicitly framed as a unique situation, yet management conceded skilled nursing deal flow is "very heavily competitive" with private buyers able to "pay up a little bit more," implying their triple-net SNF yields are under pressure from more aggressive OpCo/PropCo buyers. With skilled nursing still representing a meaningful portion of the portfolio despite the shift toward SHOP, any deterioration in this segment—driven by labor inflation or reimbursement changes—could undermine the portfolio's all-time high metrics and erode the diversification benefit management relies on for earnings stability.
SBRA's aggressive investment pipeline execution assumptions are overly optimistic given historical deal closure rates in competitive environments, risking a material shortfall in invested capital that would undermine growth guidance and leverage targets, despite management's confidence in closing the $200 million awarded pipeline. While leadership expressed no doubt about closing the $200 million awarded investments ($107 million SHOP, $94 million skilled nursing), they admitted it is "hard to tell" what percentage of the $690 million actively pursued pipeline will close due to competitive pressures, with Darrin Smith noting only a "fair number" expectation. This contrasts sharply with Richard Matros' assertion that they will "exceed pretty materially" last year's investments—a claim unsupported by historical execution rates in a rising interest rate environment where cap rate pressure is evident (most market opportunities in low-7% range). The company's reliance on forward equity issuances to fund investments on a leverage-neutral basis assumes seamless conversion of pipeline to closed deals, yet their own acknowledgment of a "competitive environment" and lack of historical closing rate disclosure suggests the market is ignoring the probability of pipeline slippage. If only 50% of the $690 million pursued pipeline closes—a conservative estimate given competitive dynamics—SBRA would deploy ~$345 million less than implied, straining liquidity and forcing either reduced investment activity (hurting growth) or increased leverage (violating target metrics), directly contradicting the narrative of ample dry powder supporting guidance stability.

Peer Comparison

Companies in the REIT - Healthcare Facilities

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	WELL	Welltower Inc.	172.91 Bn	122.84	12.78	17.93 Bn
2	VTR	Ventas, Inc.	46.62 Bn	179.03	7.60	-
3	DOC	Healthpeak Properties, Inc.	15.34 Bn	69.22	-33.80	0.25 Bn
4	OHI	Omega Healthcare Investors Inc	15.14 Bn	23.22	12.25	0.43 Bn
5	AHR	American Healthcare REIT, Inc.	10.71 Bn	194.58	4.76	1.51 Bn
6	CTRE	CareTrust REIT, Inc.	9.45 Bn	28.24	199.40	0.50 Bn
7	HR	Healthcare Realty Trust Inc	7.33 Bn	-	5.04	4.10 Bn
8	SBRA	Sabra Health Care REIT, Inc.	5.09 Bn	36.93	17.13	0.04 Bn

Research Tools

Developers

About

Investment Thesis

Consolidation Items Breakdown of Revenue (2017)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Consolidation Items Breakdown of Revenue (2017)

Peer Comparison

Create an account

Sign In

Reset Password